"/> Novus Biologicals™ Antigène protéique recombinant… | B-LABO France

Novus Biologicals™ Antigène protéique recombinant Ryanodine Receptor 1

Réf. : BL-RE-104407Réf. fabricant : 18172052 0.1 mL
242,97 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
6261
Espèces
Human
Famille de protéines
Ryanodine Receptor 1
Méthode de purification
Chromatography
Pureté
>80% by SDS-PAGE and Coomassie blue staining
Marque
Novus Biologicals

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human RYR1. The Ryanodine Receptor 1 Recombinant Protein Antigen is derived from E. coli. The Ryanodine Receptor 1 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

This is a blocking peptide for NBP2-33785. This is a human recombinant protein expressed in E. coli with a N-terminal His-ABP tag and purified with IMAC chromatography.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-104407
Réf. fabricant18172052
Gene ID (Entrez)6261
EspècesHuman
Famille de protéinesRyanodine Receptor 1
Méthode de purificationChromatography
Pureté>80% by SDS-PAGE and Coomassie blue staining
Concentration0.5mg/mL
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS and 1 M Urea, pH 7.4.
À utiliser avec (application)Antibody Competition
Symbole de gène(s)RYR1
Type d’étiquetteUnlabeled
Poids moléculaireM.W. (theoretical): 26 kDa
Type de produitRyanodine Receptor 1
Quantité0.1 mL
État réglementaireRUO
Catégorie de rechercheNeuroscience
SourceE.Coli
Réactivité spécifiqueThis recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-33785. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
ImmunogèneREFLHNNLHLQGKVEGSPSLRWQMALYRGVPGREEDADDPEKIVRRVQEVSAVLYYLDQTEHPYKSKK
Une question, une configuration particulière ?
Contactez-nous pour un devis.